Clinical spectrum and severity of hemolytic anemia in glucose 6-phosphate dehydrogenase-deficient children receiving dapsone.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Blood

• Publication date

  2012-11-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1182/blood-2012-03-416032PMID 22993389
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Haemolytic anaemia in an HIV-infected patient with severe falciparum malaria after treatment with oral artemether-lumefantrine

  2012cited by this paper
• Adverse effects of multi-drug therapy in leprosy, a two years' experience (2006-2008) in tertiary health care centre in the tribal region of Chhattisgarh State (Bastar, Jagdalpur).

  2011cited by this paper
• Unsuspected glucose-6-phosphate dehydrogenase deficiency presenting as symptomatic methemoglobinemia with severe hemolysis after fava bean ingestion in a 6-year-old boy

  2011cited by this paper
• Frequency of glucose-6-phosphate dehydrogenase deficiency in malaria patients from six African countries enrolled in two randomized anti-malarial clinical trials

  2011cited by this paper
• Dapsone hydroxylamine induces premature removal of human erythrocytes by membrane reorganization and antibody binding

  2010cited by this paper
• Medications and Glucose-6-Phosphate Dehydrogenase Deficiency

  2010cited by this paper
• The rise and fall of the antimalarial Lapdap: a lesson in pharmacogenetics.

  2010cited by this paper
• A ghostly presence—G6PD deficiency

  2010cited by this paper
• Chlorproguanil−Dapsone−Artesunate versus Artemether−Lumefantrine: A Randomized, Double-Blind Phase III Trial in African Children and Adolescents with Uncomplicated Plasmodium falciparum Malaria

  2009influential reference
• Chlorproguanil-dapsone-artesunate versus chlorproguanil-dapsone: a randomized, double-blind, phase III trial in African children, adolescents, and adults with uncomplicated Plasmodium falciparum malaria.

  2009influential reference
• Discovery, mechanisms of action and combination therapy of artemisinin

  2009cited by this paper
• The global prevalence of glucose-6-phosphate dehydrogenase deficiency: a systematic review and meta-analysis.

  2009cited by this paper
• Clinical and laboratory findings in acute malaria caused by various plasmodium species.

  2009cited by this paper
• Allelic heterogeneity of G6PD deficiency in West Africa and severe malaria susceptibility

  2009cited by this paper
• GLUCOSE-6-PHOSPHATE DEHYDROGENASE (G6PD) DEFICIENCY

  2008cited by this paper
• X-Linked G6PD Deficiency Protects Hemizygous Males but Not Heterozygous Females against Severe Malaria

  2007cited by this paper
• Adverse effects from multi-drug therapy in leprosy: a Brazilian study.

  2007cited by this paper
• Rapid epidemiologic assessment of glucose‐6‐phosphate dehydrogenase deficiency in malaria‐endemic areas in Southeast Asia using a novel diagnostic kit

  2004cited by this paper
• Comparison of chlorproguanil-dapsone with sulfadoxine-pyrimethamine for the treatment of uncomplicated falciparum malaria in young African children: double-blind randomised controlled trial.

  2004cited by this paper
• Alkylation of human hemoglobin A0 by the antimalarial drug artemisinin

  2004cited by this paper
• Assessment and monitoring of antimalarial drug efficacy for the treatment of uncomplicated falciparum malaria

  2003cited by this paper
• [Adverse effects of multidrug therapy in leprosy patients: a five-year survey at a Health Center of the Federal University of Uberlândia].

  2002cited by this paper
• Efeitos adversos da poliquimioterapia em pacientes com hanseníase: um levantamento de cinco anos em um Centro de Saúde da Universidade Federal de Uberlândia

  2002cited by this paper
• Nucleotide variability at G6pd and the signature of malarial selection in humans.

  2002cited by this paper
• Protecting Against Bad Air

  2001cited by this paper
• Malaria. Protecting against bad air.

  2001cited by this paper
• Glucose 6-Phosphate Dehydrogenase (G6PD) Deficiency

  2001cited by this paper
• Chlorproguanil‐dapsone (LAPDAP) for uncomplicated falciparum malaria

  2001cited by this paper
• Oxford textbook of medicine

  1996cited by this paper
• N-Hydroxylation of dapsone by multiple enzymes of cytochrome P450: implications for inhibition of haemotoxicity.

  1995cited by this paper
• Blood: Principles and Practice of Hematology

  1995cited by this paper
• British National Formulary

  1994cited by this paper
• Favism in the African type of glucose-6-phosphate dehydrogenase deficiency (A-).

  1990cited by this paper
• Molecular heterogeneity of glucose-6-phosphate dehydrogenase

  1989cited by this paper
• Metabolic polymorphisms and the role of infectious diseases in human evolution. 1960.

  1989cited by this paper
• Glucose-6-phosphate dehydrogenase (G6PD) deficiency in southern Italy: a case of G6PD A(-) associated with favism.

  1989cited by this paper
• Molecular heterogeneity of glucose-6-phosphate dehydrogenase A-.

  1989cited by this paper
• Bioactivation of dapsone to a cytotoxic metabolite by human hepatic microsomal enzymes.

  1989cited by this paper
• Membrane cross bonding in red cells in favic crisis: a missing link in the mechanism of extravascular haemolysis

  1985cited by this paper
• Favism and hemolytic anemia in glucose-6-phosphate dehydrogenase-deficient subjects in North Sardinia.

  1983cited by this paper
• Haemoglobinuria after a single dose treatment with dapsone and pyrimethamine for falciparum malaria in a patient with glucose-6-phosphate dehydrogenase deficiency.

  1981cited by this paper
• The hemolytic effect of primaquine V. Primaquine sensitivity as a manifestation of a multiple drug sensitivity.

  1981cited by this paper
• Haemoglobinuria after a single dose treatment with dapsone and pyrimethamine for falciparum malaria in a patient with glucose-6-phosphate dehydrogenase deficiency.

  1981cited by this paper
• Genetics of red cells and susceptibility to malaria.

  1979cited by this paper
• Variability of red cell phenotypes between and within individuals in an unbiased sample of 77 heterozygotes for G6PD deficiency in Sardinia.

  1976cited by this paper
• Letter: Temporary paralysis in childhood after influenza B.

  1975cited by this paper
• Hematology of Infancy and Childhood

  1974cited by this paper
• Glucose-6-phosphate dehydrogenase deficiency.

  1972cited by this paper
• Glucose-6-phosphate dehydrogenase and malaria. Greater resistance of females heterozygous for enzyme deficiency and of males with non-deficient variant.

  1972cited by this paper
• Standardization of procedures for the study of glucose-6-phosphate dehydrogenase. Report of a WHO Scientific Group.

  1967cited by this paper
• The haemolytic effects of diaphenylsulfone (DDS) in normal subjects and in those with glucose-6-phosphate-dehydrogenase deficiency.

  1966influential reference
• GENETIC TESTS WITH A SEX-LINKED MARKER: GLUCOSE-6-PHOSPHATE DEHYDROGENASE.

  1964cited by this paper
• Metabolic polymorphisms and the role of infectious diseases in human evolution.

  1960cited by this paper
• The hemolytic effect of primaquine and related compounds: a review.

  1959cited by this paper
• Space-Time Relationships in Somesthetic Localization

  1956cited by this paper
• Enzymatic deficiency in primaquine-sensitive erythrocytes.

  1956cited by this paper
• Space-time relationships in somesthetic localization.

  1956cited by this paper
• The hemolytic effect of primaquine. IV. The relationship of cell age to hemolysis.

  1954cited by this paper
• The hemolytic effect of primaquine. II. The natural course of the hemolytic anemia and the mechanism of its self-limited character.

  1954cited by this paper

• Scrub Typhus Infection Precipitating Hemolysis in a Patient With G6PD Deficiency: A Case Report

  2025cites this paper
• Genome sequencing of 35,024 predominantly African ancestry persons addresses gaps in genomics and healthcare

  2025cites this paper
• Outcomes of Universal Newborn G6PD Deficiency Screening in a Large Urban Cohort.

  2025cites this paper
• Molecular Mechanisms of Drug-Induced Hemolysis in G6PD Deficiency: Mechanistic Insights

  2025cites this paper
• Integrative genomic analysis identifies novel causal genes of Hodgkin’s and non-Hodgkin’s lymphoma

  2025cites this paper
• Post-Procedure Outcomes of Obese Patients after Trauma Using a Large National Dataset

  2025cites this paper
• Spider Bite Dermonecrosis: A Review of Loxoscelism

  2025cites this paper
• Integrated Phenotypic and Genotypic Approaches for Accurate Diagnosis of G6PD Deficiency: Implications for Drug Safety in Thailand

  2025cites this paper
• Increased Neutrophil H2O2 Production and Enhanced Pulmonary Clearance of Klebsiella pneumoniae in G6PD A- Mice

  2024cites this paper
• A Pleiotropic Nanomedicine Mitigates Splenic Hyperplasia, Ineffective Erythropoiesis, G6PDH Anomaly through Redox Buffering in Preclinical Mice Model

  2024cites this paper
• Pharmacogenomic Determinants of Adverse Drug Effects: A Systematic Review and Meta-analysis

  2024cites this paper
• Genetic analysis and molecular basis of G6PD deficiency among malaria patients in Thailand: implications for safe use of 8-aminoquinolines

  2024cites this paper
• Severe haemolysis during primaquine radical cure of Plasmodium vivax malaria: two systematic reviews and individual patient data descriptive analyses

  2023cites this paper
• Prevalence of G6PD deficiency and submicroscopic malaria parasites carriage in malaria hotspot area in Northwest, Tanzania

  2023cites this paper
• Molecular characterization of G6PD mutations identifies new mutations and a high frequency of intronic variants in Thai females

  2023cites this paper
• Factors affecting haemoglobin dynamics in African children with acute uncomplicated Plasmodium falciparum malaria treated with single low-dose primaquine or placebo

  2023cites this paper
• A Study of Glucose-6-Phosphate Dehydrogenase Deficiency among Children attending the Emergency Hospital in Zakho City Kurdistan Region, Iraq

  2023cites this paper
• Severe Hemolysis during Primaquine Radical Cure of Plasmodium vivax Malaria: Two Systematic Reviews and Individual Patient Data Descriptive Analyses

  2023cites this paper
• Risk of Hemolytic Anemia in IBD Patients with Glucose-6-Phosphate Dehydrogenase Deficiency Treated with Mesalamine: Results of a Retrospective-Prospective and Ex Vivo Study

  2023cites this paper
• Comparison of gene expressions in individuals with G6PD Mediterranean mutation and hemolytic anemia

  2023cites this paper
• Genetic variants causing G6PD deficiency: Clinical and biochemical data support new WHO classification

  2023cites this paper
• Hemolysis and Metabolic Lesion of G6PD Deficient RBCs in Response to Dapsone Hydroxylamine in a Humanized Mouse Model

  2023cites this paper
• Bad luck comes in threes.

  2023cites this paper
• The medication for pneumocystis pneumonia with glucose-6-phosphate dehydrogenase deficiency patients

  2022cites this paper
• Rescue Therapies for AKI in Onconephrology: Rasburicase and Glucarpidase.

  2022cites this paper
• Dapsone-induced methemoglobinemia and hemolysis in a woman without G6PD deficiency presenting with idiopathic urticaria

  2022cites this paper
• Expanded Clinical Pharmacogenetics Implementation Consortium Guideline for Medication Use in the Context of G6PD Genotype

  2022cites this paper
• A model for malaria treatment evaluation in the presence of multiple species

  2022cites this paper
• Impact of pre‐emptive rapid testing for glucose‐6‐phosphate dehydrogenase deficiency prior to rasburicase administration at a tertiary care centre: A retrospective study

  2022cites this paper
• Active Pharmacovigilance for Primaquine Radical Cure of Plasmodium vivax Malaria in Odisha, India

  2022cites this paper
• Emerging Role of Dapsone in the Management of Acne Vulgaris: Review Article

  2022cites this paper
• Treatment of gluten-related disorders

  2022cites this paper
• Dapsone for the treatment of acne vulgaris: do the risks outweigh the benefits?

  2021cites this paper
• Acute Hemolytic Anemia Caused by G6PD Deficiency in Children in Mayotte: A Frequent and Severe Complication

  2021cites this paper
• Diagnosis and clinical management of enzymopathies.

  2021cites this paper
• Acute hemolysis and methemoglobinemia secondary to fava beans ingestion in a patient with G6PD deficiency

  2021cites this paper
• The effects of glucose-6-phosphate dehydrogenase deficiency on benzene-induced hematotoxicity in mice.

  2021cites this paper
• Dynamics of G6PD activity in patients receiving weekly primaquine for therapy of Plasmodium vivax malaria

  2021cites this paper
• Basic Research of Plasmodium vivax Biology Enabling Its Management as a Clinical and Public Health Problem

  2021cites this paper
• Assessment of CareStart G6PD rapid diagnostic test and CareStart G6PD biosensor in Mauritania

  2021cites this paper
• Genotypes and phenotypes of G6PD deficiency among Indonesian females across diagnostic thresholds of G6PD activity guiding safe primaquine therapy of latent malaria

  2021influential citation
• Dosage Compensation in Females with X-Linked Metabolic Disorders

  2021cites this paper
• Role of Pharmacogenetics in Adverse Drug Reactions: An Update towards Personalized Medicine

  2021cites this paper
• Serology for plasmodium vivax surveillance: A novel approach to accelerate towards elimination.

  2021cites this paper
• Historical Experiences on Mass Drug Administration for Malaria Control and Elimination, its Challenges and China's Experience: a Narrative Review.

  2021cites this paper
• Pattern of Hemolytic Anemia Among Egyptian Pediatric Emergency Department Patients.

  2020cites this paper
• Optimizing G6PD testing for Plasmodium vivax case management: why sex, counseling, and community engagement matter.

  2020cites this paper
• Optimizing G6PD testing for Plasmodium vivax case management and beyond: why sex, counseling, and community engagement matter

  2020cites this paper
• Cost-Effectiveness Analysis of Sex-Stratified Plasmodium vivax Treatment Strategies Using Available G6PD Diagnostics to Accelerate Access to Radical Cure

  2020cites this paper
• Glucose-6-phosphate dehydrogenase enzyme deficiency in Iranian newborns: A systematic review and meta-analysis

  2020cites this paper
• Glucose-6-Phosphate Dehydrogenase Deficiency and the Benefits of Early Screening

  2020cites this paper
• Investigation of glucose-6-phosphate dehydrogenase (G6PD) deficiency prevalence in a Plasmodium vivax-endemic area in the Republic of Korea (ROK)

  2020cites this paper
• The molecular basis of bone marrow failure syndromes and red cell enzymopathies

  2019cites this paper
• Pharmacotherapeutic Approaches in Oral Medicine

  2019cites this paper
• Prevalence of Glucose-6-Phosphate Dehydrogenase Deficiency among Steady-State Sickle Cell Disease Children at University of Ilorin Teaching Hospital, Ilorin

  2019cites this paper
• [Establishment of a stable HEK293T cell line with c.392G>T (p.131G>V) mutation site knockout in G6PD gene using CRISPR/Cas9 technique].

  2019cites this paper
• Glucose-6-phosphate dehydrogenase deficiency genotypes and allele frequencies in the Kavango and Zambezi regions of northern Namibia.

  2019cites this paper
• Prevalence and distribution of G6PD deficiency: implication for the use of primaquine in malaria treatment in Ethiopia

  2019cites this paper
• High hemolytic markers in G6PD-deficient compared to G6PD-normal male leprosy patients

  2019influential citation
• Hypersensitivity Reactions to Drugs

  2019cites this paper
• Diagnostic Accuracy of G6PD Biosensor Analyzer for the Screening of Glucose-6-Phosphate Dehydrogenase Deficiency

  2019cites this paper
• Tafenoquine versus Primaquine to Prevent Relapse of Plasmodium vivax Malaria

  2019cites this paper
• Favism and Glucose-6-Phosphate Dehydrogenase Deficiency.

  2018cites this paper
• Review and drug therapy implications of glucose‐6‐phosphate dehydrogenase deficiency

  2018cites this paper
• Primaquine-induced haemolysis in females heterozygous for G6PD deficiency

  2018cites this paper
• Purification and determination the molecular weight and study the kinetic properties of Glucose-6-phosphate dehydrogenase from Diabetic patients

  2018cites this paper
• A Demographic and Biochemical Analytic of Cases of G6PD Deficiency: A Cross-Sectional Study from the Middle East

  2018cites this paper
• The Economics of Vivax Malaria Treatment

  2018cites this paper
• Glucose-6-phosphate dehydrogenase activity measured by spectrophotometry and associated genetic variants from the Oromiya zone, Ethiopia

  2018cites this paper
• Demethylcurcumin analogs, the highly potent compounds for antioxidation in G6PD normal and deficient subjects

  2018cites this paper
• Validation of the quantitative point-of-care CareStart biosensor for assessment of G6PD activity in venous blood

  2018cites this paper
• Redox Status, Procoagulant Activity, and Metabolome of Fresh Frozen Plasma in Glucose 6-Phosphate Dehydrogenase Deficiency

  2018cites this paper
• Use of primaquine and glucose-6-phosphate dehydrogenase deficiency testing: Divergent policies and practices in malaria endemic countries

  2018cites this paper
• Favism and Glucose-6-Phosphate Dehydrogenase Deficiency.

  2018cites this paper
• The enzymopathy of G 6 PD deficiency in Jordan : a demograph ic and biochemical analysis

  2018cites this paper
• Purification, Determination Molecular Weight and Study Kinetic Properties of G6PD from Diabetes Patient

  2017cites this paper
• Hemolytic Potential of Tafenoquine in Female Volunteers Heterozygous for Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency (G6PD Mahidol Variant) versus G6PD-Normal Volunteers

  2017cites this paper
• Using G6PD tests to enable the safe treatment of Plasmodium vivax infections with primaquine on the Thailand-Myanmar border: A cost-effectiveness analysis

  2017influential citation
• Low serum ferritin and G6PD deficiency as potential predictors of anaemia in pregnant women visiting Prime Care Hospital Enugu Nigeria

  2017influential citation
• Dapsona: actualización de un fármaco clásico en usos dermatológicos actuales

  2017cites this paper
• Biochemical and Molecular Assessment of Toxicity of Primaquine Metabolites on Erythrocytes

  2017cites this paper
• Validation of the rapid test Carestart(tm) G6PD among malaria vivax-infected subjects in the Brazilian Amazon.

  2016cites this paper
• Fatal Primaquine-Induced Hemolysis in a Patient With Plasmodium vivax Malaria and G6PD A(-) Variant in the Brazilian Amazon.

  2016cites this paper
• Glucose-6-Phosphate Dehydrogenase Deficiency.

  2016cites this paper
• Advances in Malaria Research

  2016cites this paper
• The Redox Cycler Plasmodione Is a Fast-Acting Antimalarial Lead Compound with Pronounced Activity against Sexual and Early Asexual Blood-Stage Parasites

  2016cites this paper
• Screening for Glucose-6-Phosphate Dehydrogenase Deficiency Using Three Detection Methods: A Cross-Sectional Survey in Southwestern Uganda.

  2016cites this paper
• Favism, the commonest form of severe hemolytic anemia in Palestinian children, varies in severity with three different variants of G6PD deficiency within the same community.

  2016cites this paper
• Prevalence and molecular characterization of G6PD deficiency in two Plasmodium vivax endemic areas in Venezuela: predominance of the African A-202A/376G variant

  2016cites this paper
• Integrating pharmacogenomics into electronic health records with clinical decision support.

  2016cites this paper
• Red Cell Glucose 6-Phosphate Dehydrogenase Deficiency in the Northern Region of Turkey: Is G6PD Deficiency Exclusively a Male Disease?

  2015cites this paper
• Systemic use of non-biologic agents in orofacial diseases: other immunomodulatory agents.

  2015cites this paper
• Glucose-6-Phosphate Dehydrogenase Deficiency and Haemoglobin Drop after Sulphadoxine-Pyrimethamine Use for Intermittent Preventive Treatment of Malaria during Pregnancy in Ghana – A Cohort Study

  2015cites this paper
• Screening and Vaccinations in Patients Requiring Systemic Immunosuppression: An Update for Dermatologists

  2015cites this paper
• Evaluation of the Diagnostic Accuracy of CareStart G6PD Deficiency Rapid Diagnostic Test (RDT) in a Malaria Endemic Area in Ghana, Africa

  2015cites this paper
• G6PD deficiency: a polymorphism balanced by heterozygote advantage against malaria.

  2015cites this paper
• Risks of Hemolysis in Glucose-6-Phosphate Dehydrogenase Deficient Infants Exposed to Chlorproguanil-Dapsone, Mefloquine and Sulfadoxine-Pyrimethamine as Part of Intermittent Presumptive Treatment of Malaria in Infants

  2015cites this paper
• Evolution from double to triple-antimalarial drug combinations.

  2015cites this paper
• Caring for Glucose-6-Phosphate Dehydrogenase (G6PD)-Deficient Patients: Implications for Pharmacy.

  2015cites this paper
• Chapter 30 - Drugs used in tuberculosis and leprosy

  2014cites this paper